Related Experiment Video
Updated: Jun 9, 2026

Analysis of Cerebral Vasospasm in a Murine Model of Subarachnoid Hemorrhage with High Frequency Transcranial Duplex Ultrasound
Published on: June 3, 2021
Cellular microparticles as a marker for cerebral vasospasm in spontaneous subarachnoid hemorrhage
Peter Lackner1, Anelia Dietmann, Ronny Beer
1Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria. peter.lackner@i-med.ac.at
Background And Purpose:
Spontaneous subarachnoid hemorrhage (SAH) still has a high risk for poor outcome that is frequently attributable to symptomatic cerebral vasospasm (CVS). We hypothesize that cellular microparticles (MP) play a role in the pathogenesis of CVS and may serve as biomarkers for CVS.
Methods:
In 20 consecutive SAH patients, endothelial, leukocyte, platelet, and erythrocyte MP were measured during 15 days after ictus. CVS was detected by transcranial Doppler sonography. Twenty matched volunteers served as healthy controls.
Results:
Endothelial, leukocyte, and erythrocyte MP were elevated in SAH patients compared to healthy controls. CD105(+) and CD62e(+) endothelial MP were significantly higher in SAH patients with Doppler sonographic CVS. CD105(+) endothelial MP were especially increased on the days of Doppler sonographic CVS onset. In patients experiencing cerebral infarction attributable to vasospasm, CD41(+) platelet MP were elevated in addition to endothelial MP. CD41(+) platelet MP were significantly higher in patients with any level of disability (modified Rankin Scale score ≥1) compared to those who made a full recovery (modified Rankin Scale score=0) on discharge from hospital.
Conclusions:
Endothelial MP were elevated in patients with SAH. This elevation coincided with the occurrence of Doppler sonographic CVS and therefore could be a novel biomarker for CVS. Platelet MP might be involved in the pathogenesis of cerebral infarction attributable to vasospasm, resulting in neurological morbidity.
Insights
Cellular microparticles (MPs) are elevated in spontaneous subarachnoid hemorrhage (SAH) patients. Endothelial MPs may serve as novel biomarkers for cerebral vasospasm (CVS), while platelet MPs indicate neurological damage.
Area of Science:
- Neuroscience
- Biochemistry
- Vascular Biology
Background:
- Spontaneous subarachnoid hemorrhage (SAH) carries a significant risk of poor outcomes, often due to symptomatic cerebral vasospasm (CVS).
- Cellular microparticles (MPs) are implicated in vascular disease pathogenesis.
- The role of MPs in SAH and CVS requires further elucidation.
Purpose of the Study:
- To investigate the role of cellular microparticles (MPs) in the pathogenesis of cerebral vasospasm (CVS) following spontaneous subarachnoid hemorrhage (SAH).
- To determine if MPs can serve as predictive biomarkers for CVS and neurological outcomes in SAH patients.
Main Methods:
- Quantified endothelial, leukocyte, platelet, and erythrocyte MPs in 20 SAH patients over 15 days post-ictus.
- Assessed cerebral vasospasm (CVS) using transcranial Doppler sonography.
- Compared MP levels in SAH patients with 20 healthy controls and correlated MP levels with clinical outcomes.
Main Results:
- SAH patients exhibited elevated levels of endothelial, leukocyte, and erythrocyte MPs compared to controls.
- Specific endothelial MPs (CD105+, CD62e+) were significantly higher in patients with Doppler-diagnosed CVS, particularly on days of onset.
- Elevated platelet MPs (CD41+) were associated with cerebral infarction and poorer neurological outcomes (modified Rankin Scale score ≥1).
Conclusions:
- Endothelial MPs are elevated in SAH patients and correlate with the occurrence of CVS, suggesting potential as novel CVS biomarkers.
- Platelet MPs may contribute to cerebral infarction pathogenesis in SAH patients, linking them to neurological morbidity.
- These findings highlight the potential of MPs as diagnostic and prognostic tools in managing SAH complications.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
